138 related articles for article (PubMed ID: 37852323)
21. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
22. Induction of Multidrug Resistance of Acute Myeloid Leukemia Cells by Cocultured Stromal Cells via Upregulation of the PI3K/Akt Signaling Pathway.
Chen P; Jin Q; Fu Q; You P; Jiang X; Yuan Q; Huang H
Oncol Res; 2016; 24(4):215-23. PubMed ID: 27656831
[TBL] [Abstract][Full Text] [Related]
23. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft.
Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H
Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644
[TBL] [Abstract][Full Text] [Related]
24. Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway.
Xiao Y; Deng T; Wang D
J BUON; 2020; 25(3):1607-1613. PubMed ID: 32862611
[TBL] [Abstract][Full Text] [Related]
25. Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia.
Zhang B; Deng X; You R; Liu J; Hou D; Wang X; Chen S; Li D; Fu Q; Zhang J; Huang H; Chen X
Neoplasia; 2024 Jan; 47():100952. PubMed ID: 38159363
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
Li F; Ling Q; Lian J; Chen Y; Hu C; Yang M; Zhang X; Li C; Mao S; Ye W; Li X; Lin X; Wei W; Huang X; Pan J; Qian Y; Wang J; Lu Y; Jin J
Cancer Med; 2023 Apr; 12(7):8319-8330. PubMed ID: 36621846
[TBL] [Abstract][Full Text] [Related]
27. Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.
Sandhöfer N; Metzeler KH; Rothenberg M; Herold T; Tiedt S; Groiß V; Carlet M; Walter G; Hinrichsen T; Wachter O; Grunert M; Schneider S; Subklewe M; Dufour A; Fröhling S; Klein HG; Hiddemann W; Jeremias I; Spiekermann K
Leukemia; 2015 Apr; 29(4):828-38. PubMed ID: 25322685
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
[TBL] [Abstract][Full Text] [Related]
29. LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.
Yao Q; Zhang L; Wang Y; Liu J; Yang L; Wang Y
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33969374
[TBL] [Abstract][Full Text] [Related]
30. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
31. SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.
Kodigepalli KM; Bonifati S; Tirumuru N; Wu L
Cell Cycle; 2018; 17(9):1124-1137. PubMed ID: 29911928
[TBL] [Abstract][Full Text] [Related]
32. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
Qiu L; Zhou G; Cao S
Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
[TBL] [Abstract][Full Text] [Related]
33. [Effect of Down-Regulation of ANRIL on Proliferation and Apoptosis of Kasumi-1 Cells and Its Potential Mechanism].
Zhang CS; Xu JX; Deng FH; Hu HL; Wang SQ; Huang H; Wei SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):984-989. PubMed ID: 35981351
[TBL] [Abstract][Full Text] [Related]
34. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling.
Wang P; Zhang J; Zhang H; Zhang F
Mol Cell Biochem; 2023 Mar; 478(3):433-441. PubMed ID: 35857251
[TBL] [Abstract][Full Text] [Related]
35. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
[TBL] [Abstract][Full Text] [Related]
37. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
[TBL] [Abstract][Full Text] [Related]
38. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
Sun X; Yang S; Song W
Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
[TBL] [Abstract][Full Text] [Related]
39. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
Yang Y; Dai W; Sun Y; Zhao Z
Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
[TBL] [Abstract][Full Text] [Related]
40. Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.
Wang F; Huang J; Guo T; Zheng Y; Zhang L; Zhang D; Wang F; Naren D; Cui Y; Liu X; Qu Y; Luo H; Yang Y; Wei H; Guo Y
Biochem Pharmacol; 2021 Jun; 188():114538. PubMed ID: 33831397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]